About the Wilms Tumor Session
Wilms tumor, a rare kidney cancer primarily affecting children, presents a unique challenge in cancer research. Researchers are exploring various aspects to understand its etiology and improve treatment outcomes. Genomic studies have identified mutations in genes like WT1 and CTNNB1, shedding light on the tumor's genetic basis. Advances in imaging technologies aid in early detection, crucial for successful treatment. Additionally, targeted therapies, such as those inhibiting angiogenesis or exploiting specific molecular pathways, offer promising avenues. Immunotherapy, harnessing the body's immune system to fight cancer cells, is also being investigated. Collaborative efforts between oncologists, geneticists, and immunologists are crucial in unraveling Wilms tumor's complexities and devising effective therapeutic strategies. Through interdisciplinary research, the aim is to enhance survival rates and quality of life for children battling this challenging malignancy.
Topics Covered in Wilms Tumor
Anaplastic Histology
Nephrogenic Rests
Predisposition Syndromes
Loss of Heterozygosity
Bilateral Disease
Risk-Adapted Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Wilms Tumor Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Wilms Tumor work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Wilms Tumor research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Wilms Tumor track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Wilms Tumor Conference 2027 — FAQs
What is the Wilms Tumor track at CIOC 2027?
The Wilms Tumor track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Wilms Tumor. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Wilms Tumor sessions?
Cancer researchers and clinicians, educators and students with an interest in Wilms Tumor are all welcome — whether presenting or attending.
Can I present my research in the Wilms Tumor track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Wilms Tumor sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Wilms Tumor track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.